Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:VLON

Vallon Pharmaceuticals (VLON) Stock Price, News & Analysis

Vallon Pharmaceuticals logo

About Vallon Pharmaceuticals Stock (NASDAQ:VLON)

Advanced Chart

Key Stats

Today's Range
$1.20
$1.33
50-Day Range
$0.27
$2.87
52-Week Range
$0.21
$12.92
Volume
250,209 shs
Average Volume
5.78 million shs
Market Capitalization
$17.66 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Vallon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel medications for central nervous system disorders with a focus on abuse-deterrent medications. Its lead investigational product candidate is ADAIR, an abuse-deterrent oral formulation of immediate-release dextroamphetamine for the treatment of attention-deficit/hyperactivity disorder (ADHD) and narcolepsy. The company is also developing ADMIR, an abuse deterrent formulation of methylphenidate for the treatment of ADHD. Vallon Pharmaceuticals, Inc. was incorporated in 2018 and is based in Philadelphia, Pennsylvania.

Receive VLON Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Vallon Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

VLON Stock News Headlines

Questcor Pharmaceuticals,
AI Meltdown Imminent: Dump These Stocks Now!
If you have any money in the markets, especially in AI stocks… Please click here to see Elon Musk’s new invention… This could send many popular AI stocks crashing, including Nvidia. And it could happen starting as soon as June 1st.
See More Headlines

VLON Stock Analysis - Frequently Asked Questions

Shares of Vallon Pharmaceuticals reverse split on Monday, April 24th 2023. The 1-30 reverse split was announced on Monday, April 24th 2023. The number of shares owned by shareholders was adjusted after the market closes on Monday, April 24th 2023. An investor that had 100 shares of stock prior to the reverse split would have 3 shares after the split.

Vallon Pharmaceuticals (VLON) raised $15 million in an initial public offering (IPO) on Wednesday, February 10th 2021. The company issued 1,700,000 shares at a price of $8.00-$10.00 per share. ThinkEquity (a division of Fordham Financial Management) served as the underwriter for the IPO.

Based on aggregate information from My MarketBeat watchlists, some other companies that Vallon Pharmaceuticals investors own include Meta Platforms (META), Alkaline Water (WTER), SoFi Technologies (SOFI), Exro Technologies (EXROF), AMC Entertainment (AMC), Alpha Lithium (APHLF) and Avino Silver & Gold Mines (ASM).

Company Calendar

Today
5/27/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:VLON
Fax
N/A
Employees
3
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$7.02 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$100,000.00
Price / Cash Flow
N/A
Book Value
$0.18 per share
Price / Book
6.67

Miscellaneous

Free Float
8,453,000
Market Cap
$16.18 million
Optionable
Not Optionable
Beta
-1.14
A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report

This page (NASDAQ:VLON) was last updated on 5/28/2025 by MarketBeat.com Staff
From Our Partners